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Abstract
The aim of the study. Evaluation of cardiorespiratory system and microcirculation state in elder CHD patients with dif-
ferent resistance against hypoxia.
Methods. The author has carried out a retrospective analysis of 103 CHD 60+-patients, their deaths have occurred due 
to cardiovascular events. Two patient groups have been formed including patients (68 persons) having kept their resistance to 
hypoxia (their blood SO2 level was never below 80 %) and patients (35 ones) with decreased resistance to hypoxia, their blood SO2 
level having been dropped below 80 %.
Results. The life span of patients with decreased hypoxia resistance is lower comparing to ones having kept such resis-
tance. The patients with decreased hypoxia resistance demonstrate decreased ejection fraction, increased mass of left ventricle 
myocardium as well as increased left ventricle volumes. Such patients show also significant increase of mean daily values of 
systolic, diastolic, and mean arterial pressure. Generally, the micro-circulation state in patients with decreased anti-hypoxic 
resistance is lower comparing to persons having kept this resistance. Simultaneously, the endothelial function of persons with de-
creased anti-hypoxic resistance is significantly worse. The pulmonary ventilation system patency and bronchial patency in these 
persons are also lowered comparing to these indices in patients with kept anti-hypoxic resistance.
Conclusions. The decrease of anti-hypoxic resistance leads to the shorter life span on elderly CHD patients. Such decreased 
resistance is accompanied by worsened potency of cardio-respiratory system, microcirculation, and endothelial system functioning.
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1. Introduction
The hypoxia development is a typical ageing-accompanying pathological process leading 
to numerous limitations concerning the course of both infection-due and non-infectious diseases 
including also ischemic heart damage [1, 2]. In elderly persons, the decrease of oxygen transport 
function leads to the development of arterial hypoxemia and heavy tissue hypoxia causing the de-
crease of anti-hypoxic resistance and the development of oxygen deficiency [3, 4].
The anti-hypoxic resistance of the organism means not only the state of anti-hypoxic resis-
tance, but also its resistance against a lot of other non-favourable factors [5, 6]. The anti-hypoxic 
resistance is a homeostasis supporting factor in conditions of hypoxia. Such organism’s resistance 
may be determined as a limit oxygen concentration in inspired air, the homeostasis being damaged 
below this concentration [7].
The hypoxia process and hypoxia beginning could be present in the majority of pathological 
processes and diseases [8, 9]. For example, the development of hypoxia is a key link of cardiovas-
cular pathologies, in particular, of the coronary heart disease CHD. The disturbance of coronary 
blood stream in CHD patients leads to myocardium ischemia; later the development causes the 
decreased functioning efficacy of the cardiovascular system. It promotes the appearance of circu-
latory hypoxia and hypoxia-due changes in the organism accompanying the decrease of organism’s 
resistance against hypoxia [10].
In cases of CHD development in elderly patients, pathology-due damages caused by hypoxia 
are usually put on age-due changes. In such situation the development and progress of hypoxia-due 
disturbances in elderly CHD patients exhaust compensatory mechanisms of the organism and may 
be fatal [1, 11].
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The development of anti-hypoxic resistance is a complex process being multi-compo-
nent and of different directions. Numerous investigations demonstrate important mechanisms of 
anti-hypoxic resistance to include, together with respiratory system, also oxygen-transporting system 
of blood, cardiovascular system state as well as endothelium dysfunction and changes of micro-cir-
culation [12, 13]. The morpho-functional state of elderly CHD patients with different anti-hypoxic 
resistance have been not investigated, it was quite worth to study this problem. In particular, there 
were no data concerning the state of cardio-respiratory system and microcirculation in elderly CHD 
patients with different anti-hypoxic resistance who had died because of cardiovascular events.
The aim of the study. Evaluation of cardio-respiratory system and micro-circulation state 
in elder CHD patients with different resistance against hypoxia who have died because of cardio-
vascular events. 
2. Materials and methods
The author carried out a retrospective analysis of 103 CHD 60+-patients treated during 
2005–2019 of the State Institution “Dmitry F. Chebotarev Institute of Gerontology of the National 
Academy of Medical Sciences of Ukraine”, their deaths have occurred due to cardiovascular events. 
This investigation was approved by the Ethic Commission of the State Institution “Dmit- 
ry F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukrai- 
ne” No. 8 (21.12.2017). The CHD diagnoses were verified according to current international proto-
cols and to the order of the Ministry of Health of Ukraine No. 152 (02.03.2016) [14, 15]. The work 
was carried out in accordance with the principles of the Declaration of Helsinki.
The evaluation of anti-hypoxic resistance of our patients was realized according to the re-
sults of a hypoxic test determined [inspiration of hypoxic gas mixture with 12 % O2 during 20 min, 
the blood saturation (SO2) being monitored].
Two patient groups have been formed for patients having reached the final point: patients 
(68 persons) having kept their resistance to hypoxia (their blood SO2 level has been never below 
80 %) and patients (35 ones) with decreased resistance to hypoxia, their blood SO2 level have been 
dropped below 80 %. The SO2 level was chosen as a criterion showing the patient’s decrease of 
anti-hypoxic resistance taking into account the following reasoning. It is known the degrees of 
hypoxic damaging effect are determined as compensation, sub-compensation, and de-compensa- 
tion [16]. The sub-compensation phase is usually developed following the inspiration of gas mix-
ture containing 12–12.5 % of SO2 and corresponding to the blood saturation level about 78–80 %. 
According to the data of Kolchinskaya et al., the oxygen tension in tissues reaches in this case 
45–50 mm Hg and leads to tissue structural damage [17]. Consequently, the SO2 level having 
reached 80 % is the limit level and may be used for evaluation of anti-hypoxic resistance. 
The analysis of morpho-functional state of the cardiovascular system was made using 
two-dimensional echocardiography and daily monitoring of arterial pressure.
Pulmonary ventilation function was evaluated according to spirometry data.
The state of microcirculation and of endothelial function was studied using the laser flow-
metry and the data of voluminous speed of skin blood flow using a test with reactive hyperemia. 
Statistical data evaluation was realized using variation statistics approaches and the com-
puter program Excel 2010 (Microsoft Office 2010, Product ID: 02954-076-111196, Order ID: 
6368848992). All the studied indices have distributions close to normal ones; consequently, para-
metric statistical approaches were used. The normality of data distribution was checked using 
Kolmogorov-Smirnov and Shapiro-Wilk tests. Each distribution was thought to be normal in cases 
of p>0.05. Mean values (M) and their errors (m) were calculated. The t-test of Student was taken 
for to compare quantitative indices. The differences were thought to be statistically significant at 
the p value <0.05.
3. Results
3. 1. Status of the cardiovascular system
The analysis of results demonstrates the life span of persons with decreased anti-hypoxic re-
sistance to be significantly shorter comparing to patients with kept resistance (69.32±5.21 against 
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74.49±4.07 years, p<0.05). At the same time, a significant decrease of left ventricle ejection fraction, 
increase of left ventricle myocardium mass and of left ventricle myocardium mass index were found 
as well as cavity dilatation in patients died later with decreased anti-hypoxic resistance (Table 1). 
Table 1
Mean values describing structural and functional myocardium state of CHD patients of elderly age with 
different anti-hypoxic resistance.
Indices Increased anti-hypoxic resistance Kept anti-hypoxic resistance
RF, % 48.1±0.1 50.±0.2*
LVPW, cm 1.3±0.02 1.2±0.02
IVS, cm 1.3±0,01 1.2±0.01
ESV, cm 4.01±0.02 3.9±0.02*
EDV, cm 5.8±0.02 5.5±0.02*
LVMM, g/m2 277±2.2 263±2.2*
LVMMI, g/m2 168.1±3.9 156.6±2.06*
Notes: * – differences are significant comparing to the group with decreased anti-hypoxic resistance, p<0.05. There are presented 
data as M±m; LVPW – posterior wall of the left ventricle; IVS – inter-ventricle septum; EDV – end diastolic volume; ESV – end 
systolic volume; EF – ejection fraction; LVMM – left ventricle myocardium mass; LVMMI – left ventricle myocardium mass index
Analysis of indices of daily arterial pressure monitoring in elderly CHD patients with de-
creased anti-hypoxic resistance demonstrates significant increase of mean daily values for systolic 
blood pressure (BP), diastolic BT, and mean BT comparing to elderly CHD patients having kept 
their anti-hypoxic resistance (Table 2). The patients with decreased anti-hypoxic resistance are 
also shown to have significantly higher values of mean daily pulse BT comparing to ones with kept 
anti-hypoxic resistance (Table 2).
Table 2
Mean values of daily AT monitoring in elderly CHD patients with different anti-hypoxic resistance
Indices Increased anti-hypoxic resistance Kept anti-hypoxic resistance
Mean daily SBP, mm Hg 159.0±12.7 120.2±12.5*
Mean daily DBP, mm Hg 89.2±3.75 72.8±3.75*
Mean daily BTmean, mm Hg 126.33±2.7 115.03±2.6
*
Mean daily PBP, mm Hg 58.76±2.2 52.56±1.02*
Area index 28.7±4.7 15.2±4.7*
Note: * – differences are significant comparing to the group with decreased anti-hypoxic resistance, p<0.05; SBP – systolic BP; 
DBР – diastolic BP; PBP – pulse BP. The data are presented as M±m
3. 2. State of microcirculation and endothelial function
The analysis of conducted studies demonstrates the state of tissue perfusion on the mi-
cro-vessel level to be on the whole significantly lower in CHD patients with decreased anti-hypoxic 
resistance comparing to ones with kept resistance. It is proved by slight, but significant decrease of 
voluminous speed of skin blood flow (VSSBF) in such patients (Table 3). The VSSBF increase on 
the peak of reactive hyperemia in patients with decreased anti-hypoxic resistance is also less mani-
fested comparing to ones having kept such resistance (Table 3). Simultaneously, following reactive 









The state of blood flow in micro-vessels during test with reactive hyperemia in elderly CHD patients with 
different anti-hypoxic resistance
Indices Increased anti-hypoxic resistance Kept anti-hypoxic resistance
Background VSSBF value, mL/min ×100 g 1.37±0.05 1.53±0.04*
VSSBF value on the peak of reaction, mL/min ×100 g 3.77±0.25 5.28±0.28*
VSSBF, mL/min ×100 g 2.42±0.13 3.75±0.14*
Duration of peak reaction development, s 23.5±2.5 14.4±21*
Duration of recovery, s 94.2±5.5 117.47±6.1*
Note: * – differences are significant comparing to the group with decreased anti-hypoxic resistance, p<0.05; VSSBF – voluminous 
speed of skin blood flow. The data are presented as M±m
3. 3. Pulmonary ventilation function and bronchial patency
The conducted studies permit to declare the pulmonary ventilation function and bronchial 
patency to be significantly lower in patients with decreased anti-hypoxic resistance comparing to 
ones having kept such resistance (Table 4).
Table 4
Mean values of indices describing pulmonary ventilation function and bronchial patency in elderly CHD 
patients with decreased anti-hypoxic resistance comparing to ones having kept such resistance
Indices Increased anti-hypoxic resistance Kept anti-hypoxic resistance
VE, L/min 8.26±0.23 8.47±0.34
MVV, L/min 63.77±2.44 77.82±2.29*
FVC, L 2.62±0.28 3.08±0.22*
FEV1, L/s 1.62±0.21 2.13±0.18
*
FEV1/FVC, % 61.83±1.48 69.16± 2.11
*
Note: * – differences are significant comparing to the group with decreased anti-hypoxic resistance, p<0.05. The data are presented 
as M±m. VE – lung ventilation during a minute; MVV – maximal lung ventilation; FVC – vital lung capacity; FEV1  – volume of forced 
respiration during the first second
4. Discussion
The life span decrease in elderly CHD patients with lowered anti-hypoxic resistance proves 
such resistance lowering to be an unfavourable risk factor. At the same time, some current inves-
tigations show the anti-hypoxic resistance of elderly CHD patients to be dependent on the state of 
cardiovascular system. 
Hypoxia and related disturbances are a key mechanism of the CHD. The local myocardium 
hypoxia developed as a result of coronary arteries atherosclerosis in CHD patients leads to the 
lowering of myocardium function possibilities. On the other hand, it may promote the decrease 
of oxygen transport, development of circulatory hypoxia, and decrease of anti-hypoxic resistance. 
The analysis of obtained data demonstrates the anti-hypoxic resistance in elderly CHD patients to 
be also a result of worsened structural and functional state of myocardium.
The level of blood pressure is dependent on the state of cardiovascular system. Simulta-
neously, the level of blood pressure influences on oxygen transport, oxygen providing to tissues, 
and anti-hypoxic resistance. On the other hand, the blood pressure level is an important index for 
evaluation of cardiovascular risk and prediction of cardiovascular events. The BP level describes 
(reflects) a dynamic component of the pressure on target organs as well as an rigidity indicator of 
large arterial vessels. The BP increase in elderly CHD patients with decreased anti-hypoxic resis-
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tance may lead to the development of peripheral vasospasm. It is just an event being able to cause 
the blood flow disturbance, decrease of oxygen providing for tissues, appearance of tissue hypoxia, 
and decrease of anti-hypoxic resistance.
The possible causes of disturbances concerning microcirculation and endothelial function 
in elderly CHD patients with decreased anti-hypoxic resistance are decreased micro-vessel diame-
ters and lowered quantity of capillary vessels as well as worsening of rheological blood properties. 
On the other hand, the worsening of microcirculation in patients with decreased anti-hypoxic resis-
tance comparing to ones having kept this resistance is a result of inhibited synthesis of endothelial 
vasodilators and of endothelial dysfunction development. Less expressive VSSBF increase on the 
peak of reactive hyperemia in patients with decreased anti-hypoxic resistance as well as signifi-
cantly lowered recovery potential post hyperemia are proves of worsened endothelium function due 
to decreased nitrogen oxide synthesis.
The obtained data testify the microcirculation disturbance and endothelium dysfunction 
develop a danger for oxygen providing to the organism promoting the decrease of anti-hypoxic 
resistance in elderly CHD patients. 
Pulmonary ventilation function and bronchial patency are a key link in adaptive mechanism 
to hypoxic conditions in elderly CHD patients [18–20]. The reaction of lung ventilation mechanism 
on hypoxia is realized through chemo-receptors of the aorta arc and respiratory center responding 
on the decreased blood oxygen tension during the development of arterial hypoxia. The anti-hypox-
ic resistance is mostly due to adequacy of ventilation response on hypoxia. 
The investigations showed the decreased anti-hypoxic resistance of elderly CHD patients 
to be a consequence of changes in pulmonary ventilation function and bronchial patency. It is 
confirmed by the FVC decrease in patients with decreased anti-hypoxic resistance. Reserve venti-
lation possibilities proved by the MVV decrease are also lower in such patients (Table 4). It is also 
important the bronchial patency to be significantly lower in patients with decreased anti-hypoxic 
resistance comparing to ones having kept it (Table 4). Consequently, it is possible the decreased 
pulmonary function of ventilation as well as lowered bronchial patency to be among mechanisms 
causing the decrease of anti-hypoxic resistance in elderly CHD patients.
The studies were limited to elucidating the features of the functioning of the cardiorespira-
tory system in elderly patients with coronary artery disease with reduced and preserved resistance 
to hypoxia.
Prospects for further research are to develop a model for predicting life expectancy in 
elderly patients with coronary artery disease, depending on resistance to hypoxia.
5. Conclusions
1. The decreased anti-hypoxic resistance leads to shortened life span in elderly CHD pa-
tients, such a fact being a risk factor of unfavourable cardiovascular events in these patients.
2. The decreased anti-hypoxic resistance in elderly CHD patients is especially due to struc-
tural and functional changes of cardio-respiratory system, microcirculation, and endothelium func-
tion. In such patients the functioning efficacy of cardio-respiratory system, microcirculation, and 
endothelium function are decreased.
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